Fig. 2

Expression profile of TLR2 and TLR7 protein level in CD8⁺ T cells from peripheral bloods of NCs (n = 23), peripheral bloods of GC patients (n = 32), and tumor-residency of GC patients who underwent surgery (n = 21). Cells were stained with anti-CD3, anti-CD8, anti-TLR2, and anti-TLR7. The percentage of TLR2 and TLR7 positive cells within CD3⁺CD8⁺ T cells was analyzed by flow cytometry. a The representative flow dots for TLR2⁺ and TLR7⁺ cells within CD3⁺CD8⁺ T cells were shown. The percentage of b TLR2⁺ and c TLR7⁺ cells within CD3⁺CD8⁺ T cells was compared peripheral bloods of NCs, peripheral bloods of GC patients, and tumor-residency of GC patients. The columns indicated means, and the bars indicated standard deviation. Significances were determined by One-Way ANOVA and LSD-t test